latest news releases from the newsroom
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals to Present at SG Cowen & Co. 25th Annual Health Care Conference
NEW YORK, March 11, 2005 (PRIMEZONE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), announced today that Michael S. Weiss, Chairman and Chief Executive Officer, will present an overview of the Company, including recent progress and upcoming milestones at the SG Cowen & Co. 25th Annual Health Care Conference in Boston. Mr. Weiss' presentation will take place on Wednesday, March 16, 2005 at 3:10 p.m. Eastern Time in Salon C of the Marriott Copley Place Hotel. A live audio webcast of Mr. Weiss' presentation will be available at http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=KERX&item_id=1026068. An archived version of the webcast will be available beginning approximately 1 hour after the live presentation.
Labaton Sucharow LLP
Goodkind Labaton Rudoff & Sucharow LLP to File Second Amended Complaint; Filing Due Date is Extended to April 1, 2005 -- CECO
NEW YORK, March 11, 2005 (PRIMEZONE) -- Goodkind Labaton Rudoff & Sucharow LLP, the Court designated lead counsel in a class action against Career Education Corp., (Nasdaq:CECO), John M. Larson and Patrick K. Pesch, on behalf of purchasers of Career Education securities between January 8, 2003 and December 2, 2003, inclusive, announces that it will file its second amended complaint on April 1, 2005.
Micron Enviro Systems, Inc.
Micron Enviro Systems Announces New Multi-Well Oil and Gas Prospect in Final Negotiation Stage
VANCOUVER, British Columbia, March 11, 2005 (PRIMEZONE) -- Micron Enviro Systems, Inc. (OTCBB:MSEV) is pleased to announce that it has entered into final negotiations on a new multi-well oil and gas prospect in a world-class producing region of Alberta, Canada. This prospect is located in the Pembina Area, which is the largest conventional oil field in Canada. A final decision on this new prospect is expected to be completed within the next week. This prospect is scheduled to commence operations within the next 10-20 days.
Hard to Treat Diseases, Inc.
Hard to Treat Diseases, Incorporated Announces Negotiation, Mediation and Trial Schedule
DELRAY BEACH, Fla., March 11, 2005 (PRIMEZONE) -- Hard to Treat Diseases, Incorporated (HTTD) (Pink Sheets:HTDS) announces today that negotiations and mediation with Ronald Shinn, Gerry Knight, and Shinn Capital Group regarding the current business-related dispute are being scheduled to occur in the near future. The scheduling is being coordinated so that all the parties, their counsel, and the mediator are available to participate. The scheduling of mediation and discussions comply with the Court's Order referring the parties to mediation, but also reflects the Court's recommendation to seek a negotiated resolution. As the Company has continually maintained, a negotiated business resolution would be in the best interests of the parties and HTTD's shareholders.
Ben Franklin Technology Partners of Southeastern Pennsylvania
Take a Bow: Entrepreneurs Honored, Innovation Celebrated at the 2005 Ben Franklin Emerging Business Awards
PHILADELPHIA, March 11, 2005 (PRIMEZONE) -- Four innovative, up and coming, emerging companies and their management teams were honored Thursday evening, March 10, 2005, for their extraordinary achievements at the 11th Annual Ben Franklin Emerging Business Awards, affectionately known as The Bennies. The accomplishments of MacroArray Technologies, LLC, PartySpace.com, Really Strategies, Inc. and Nucleonics, Inc. were all celebrated at the event held at the Wyndham Franklin Plaza in Philadelphia.